Detalhe da pesquisa
1.
Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity.
Proc Natl Acad Sci U S A
; 120(16): e2205085120, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036990
2.
Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD.
Blood
; 140(25): 2740-2753, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084473
3.
Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
Blood
; 138(17): 1628-1636, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34269803
4.
Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity.
Blood
; 137(16): 2243-2255, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33511398
5.
Durable discontinuation of systemic therapy in patients affected by chronic graft-versus-host disease.
Haematologica
; 108(2): 483-489, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615925
6.
How I treat steroid-refractory acute graft-versus-host disease.
Blood
; 135(19): 1630-1638, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32202630
7.
CD24Fc to DAMPen GVHD.
Blood
; 143(1): 1-2, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175676
8.
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica
; 106(6): 1599-1607, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499241
9.
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.
Ann Intern Med
; 172(4): 229-239, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31958813
10.
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(5): 835-844, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31505228
11.
Disability Related to Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(4): 772-777, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31669175
12.
Lithium attenuates graft-versus-host disease via effects on the intestinal stem cell niche.
Blood
; 141(3): 315-319, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201741
13.
Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.
Biol Blood Marrow Transplant
; 25(3): 451-458, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447393
14.
Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 25(9): 1869-1874, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085305
15.
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.
Biol Blood Marrow Transplant
; 25(12): 2468-2473, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394265
16.
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.
Biol Blood Marrow Transplant
; 25(7): 1424-1431, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871976
17.
Sitagliptin to Prevent Acute Graft-versus-Host Disease.
N Engl J Med
; 384(1): 70-71, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406333
18.
Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
Blood
; 129(6): 791-798, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27872059
19.
Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation.
Blood
; 129(19): 2693-2701, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28270451
20.
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.
Blood
; 130(3): 360-367, 2017 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495794